BR0314088A - Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas - Google Patents

Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas

Info

Publication number
BR0314088A
BR0314088A BR0314088-1A BR0314088A BR0314088A BR 0314088 A BR0314088 A BR 0314088A BR 0314088 A BR0314088 A BR 0314088A BR 0314088 A BR0314088 A BR 0314088A
Authority
BR
Brazil
Prior art keywords
birds
adjuvant
escherichia coli
poultry
coli toxin
Prior art date
Application number
BR0314088-1A
Other languages
English (en)
Inventor
Timothy J Miller
Matthew J Fanton
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Publication of BR0314088A publication Critical patent/BR0314088A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"USO DE TOXINA DE ESCHERICHIA COLI LáBIL AO CALOR COMO UM ADJUVANTE EM PáSSAROS E AVES DOMéSTICAS". A presente invenção refere-se à composições e método de emprego da toxina de E. coli lábil ao aquecimento (LT) e análogos conhecidos como adjuvantes em pássaros. A invenção também fornece composições e métodos para empregar LT produzida de planta, seus análogos conhecidos, e imunógenos protetores como vacinas em pássaros.
BR0314088-1A 2002-08-27 2003-08-27 Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas BR0314088A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40635902P 2002-08-27 2002-08-27
PCT/US2003/026721 WO2004020585A2 (en) 2002-08-27 2003-08-27 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry

Publications (1)

Publication Number Publication Date
BR0314088A true BR0314088A (pt) 2005-07-19

Family

ID=31978291

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314088-1A BR0314088A (pt) 2002-08-27 2003-08-27 Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas

Country Status (12)

Country Link
US (1) US20040146533A1 (pt)
EP (1) EP1551451B1 (pt)
JP (1) JP2005539039A (pt)
CN (1) CN100435844C (pt)
AR (1) AR041090A1 (pt)
AT (1) ATE423569T1 (pt)
AU (1) AU2003274925A1 (pt)
BR (1) BR0314088A (pt)
CA (1) CA2491568A1 (pt)
DE (1) DE60326369D1 (pt)
ES (1) ES2320119T3 (pt)
WO (1) WO2004020585A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100387719C (zh) * 2005-05-09 2008-05-14 中国农业科学院生物技术研究所 编码大肠杆菌热敏毒素基因及其表达载体和用途
JP5014413B2 (ja) 2006-03-30 2012-08-29 エンブレックス・インコーポレイテッド 家禽のワクチン接種のための方法及び組成物
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
AU2009283557B2 (en) * 2008-08-18 2013-01-17 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration
CA2785653C (en) * 2009-12-28 2018-05-01 Merial Limited Recombinant ndv antigen and uses thereof
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
IT1253009B (it) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
EP0793717B1 (en) * 1994-10-24 2005-01-26 The Texas A & M University System Oral immunization with transgenic plants
US6395964B1 (en) * 1995-10-24 2002-05-28 The Texas A&M University System Oral immunization with transgenic plants
AU773953B2 (en) * 1998-12-22 2004-06-10 Boyce Thompson Institute For Plant Research Inc. Orally immunogenic bacterial enterotoxins expressed in transgenic plants

Also Published As

Publication number Publication date
WO2004020585A2 (en) 2004-03-11
WO2004020585B1 (en) 2004-10-07
CN100435844C (zh) 2008-11-26
CN1678343A (zh) 2005-10-05
AU2003274925A1 (en) 2004-03-19
JP2005539039A (ja) 2005-12-22
US20040146533A1 (en) 2004-07-29
EP1551451A2 (en) 2005-07-13
EP1551451B1 (en) 2009-02-25
ATE423569T1 (de) 2009-03-15
WO2004020585A3 (en) 2004-08-12
CA2491568A1 (en) 2004-03-11
ES2320119T3 (es) 2009-05-19
DE60326369D1 (de) 2009-04-09
AU2003274925A8 (en) 2004-03-19
AR041090A1 (es) 2005-05-04
EP1551451A4 (en) 2005-11-16

Similar Documents

Publication Publication Date Title
PT777490E (pt) Enterotoxina mutante eficaz como adjuvante oral nao toxico
BR9510263A (pt) Novo derivado de ciclodextrina processo para sua preparação utilização dos mesmos composição terapêutica e adjuvante para vacinas
BRPI0007936B8 (pt) composto, formulação adjuvante imunológica, e formulação de vacina.
NO20082472L (no) Vaksinesammensetninger omfattende en saponin adjuvant
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
NO20015073D0 (no) Vaksiner
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
NO20061912L (no) Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
MY149604A (en) C.perfringens alpha toxoid vaccine
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
BR0111834A (pt) Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
BR0314088A (pt) Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas
CY1110327T1 (el) DTPa ΕΜΒΟΛΙΑ ΒΛΕΝΝΟΓΟΝΟΥ
ATE392216T1 (de) Mycobakterieller impfstoff
DE60115051D1 (de) Immunologische adjuvans verbindungen
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
TW200503755A (en) Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
BR9915533A (pt) Preparações de vacina contendo toxina atenuada
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
AR011592A1 (es) Metodo de creacion, o mantenimiento o para inducir una inmuno respuesta protectora o adaptativa a un virus hiv en un huesped
BRPI0417880A (pt) vacina de combinação para a proteção de aves domésticas contra ornithobacterium rhinotracheale, uso de uma cepa de ornithobacterium rhinotracheale superatenuada viva e um vìrus de aves domésticas atenuado, método para a preparação de uma vacina de combinação, e, kit de vacinação
ES2127702A1 (es) Vacuna frente a vibriosis producida por vibrio vulnificus biotipo 2 en anguilas.
EP0178928A3 (en) Vaccines

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2164 DE 26/06/2012.